CYRAMZA
Active substance: ramucirumab
SOLUTION · RAMUCIRUMAB 10 mg/mL
United StatesActive
Marketing holder: Eli Lilly and Company
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- RAMUCIRUMAB · 10 mg/mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-dde2-70ec-8554-fc7a71a01476,01a1208d-d0b7-7133-b918-66a34488e63c;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0002-7669
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 0002-7669 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0002-7669 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0002-7669 · Verified 2026-10-09 · open in source